ASANA INC - CL A (ASAN)

US04342Y1047 - Common Stock

23.65  -2.67 (-10.14%)

After market: 23.64 -0.01 (-0.04%)

Fundamental Rating

3

ASAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 278 industry peers in the Software industry. The financial health of ASAN is average, but there are quite some concerns on its profitability. ASAN is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

ASAN had negative earnings in the past year.
In the past year ASAN has reported a negative cash flow from operations.
ASAN had negative earnings in each of the past 5 years.
In the past 5 years ASAN always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -27.51%, ASAN is not doing good in the industry: 75.54% of the companies in the same industry are doing better.
ASAN has a worse Return On Equity (-89.09%) than 74.82% of its industry peers.
Industry RankSector Rank
ROA -27.51%
ROE -89.09%
ROIC N/A
ROA(3y)-36.73%
ROA(5y)-33.46%
ROE(3y)-111.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 89.67%, ASAN belongs to the top of the industry, outperforming 96.76% of the companies in the same industry.
ASAN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ASAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.93%

4

2. Health

2.1 Basic Checks

ASAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ASAN has more shares outstanding
ASAN has more shares outstanding than it did 5 years ago.
ASAN has a better debt/assets ratio than last year.

2.2 Solvency

ASAN has an Altman-Z score of 3.17. This indicates that ASAN is financially healthy and has little risk of bankruptcy at the moment.
ASAN has a Altman-Z score (3.17) which is comparable to the rest of the industry.
ASAN has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
ASAN's Debt to Equity ratio of 0.14 is in line compared to the rest of the industry. ASAN outperforms 46.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 3.17
ROIC/WACCN/A
WACC11.64%

2.3 Liquidity

ASAN has a Current Ratio of 1.63. This is a normal value and indicates that ASAN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ASAN (1.63) is comparable to the rest of the industry.
ASAN has a Quick Ratio of 1.63. This is a normal value and indicates that ASAN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ASAN (1.63) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.63

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.87% over the past year.
Looking at the last year, ASAN shows a quite strong growth in Revenue. The Revenue has grown by 19.24% in the last year.
ASAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.41% yearly.
EPS 1Y (TTM)46.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)19.24%
Revenue growth 3Y42.18%
Revenue growth 5Y53.41%
Sales Q2Q%10.44%

3.2 Future

ASAN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.57% yearly.
ASAN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.10% yearly.
EPS Next Y6.99%
EPS Next 2Y35.1%
EPS Next 3Y39.15%
EPS Next 5Y29.57%
Revenue Next Year10.93%
Revenue Next 2Y11.28%
Revenue Next 3Y11.8%
Revenue Next 5Y14.1%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

ASAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ASAN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ASAN's earnings are expected to grow with 39.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.1%
EPS Next 3Y39.15%

0

5. Dividend

5.1 Amount

ASAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASANA INC - CL A

NYSE:ASAN (12/18/2024, 4:32:48 PM)

After market: 23.64 -0.01 (-0.04%)

23.65

-2.67 (-10.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.41B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.51%
ROE -89.09%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 89.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.63
Quick Ratio 1.63
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)46.87%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y6.99%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.24%
Revenue growth 3Y42.18%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y